Comparison of Pathologic Tumor Necrosis of Conventional Versus Ultrahypofractionated Preoperative Radiation Therapy in Localized Extremity Soft Tissue Sarcoma and Its Correlation With Clinical Outcomes

被引:0
|
作者
Hana, Hanis [1 ]
Freeman, Carolyn R. [1 ]
Tsui, James [1 ]
Ramia, Paul [1 ]
Turcotte, Robert [2 ]
Aoude, Ahmed [2 ]
Bozzo, Anthony [2 ]
Cury, Fabio L. [1 ]
机构
[1] McGill Univ, Hlth Ctr, Dept Oncol, Div Radiat Oncol, Montreal, PQ, Canada
[2] McGill Univ Hosp Ctr, Dept Orthopaed, Montreal, PQ, Canada
关键词
RADIOTHERAPY; CHEMOTHERAPY;
D O I
10.1016/j.prro.2024.10.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We aimed to determine if ultrahypofractionated radiation therapy (UHYPO-RT) delivering 6 Gy x 5 fractions yields similar tumor necrosis compared with conventional radiation therapy (CONV-RT) with 2 Gy x 25 fractions in soft tissue sarcoma. The clinical significance of tumor necrosis on loco-regional recurrence-free survival (LRFS), distant disease-free survival (DDFS), and overall survival (OS) were assessed. Methods and Materials: Patients with localized soft tissue sarcoma treated with CONV-RT or UHYPO-RT followed by surgery were included. Good response was defined as tumor necrosis >= 90%, and poor response as <90%. The Mann-Whitney U test compared median tumor necrosis. x2 analysis was used for categorical variables. The Kaplan-Meier function estimated LRFS, DDFS, and OS. Results: A total of 64 patients received CONV-RT, and 45 received UHYPO-RT. The median tumor size was 7.0 cm, with the lower extremity being the most common site (55%). Myxofibrosarcoma (39%) and undifferentiated pleomorphic sarcoma (16%) were the most frequent histologies. The median time from radiation therapy to surgery was 35 days. There was a significant difference in median tumor necrosis between CONV-RT and UHYPO-RT, with rates of 40% and 60%, respectively (P = .022). Patients receiving UHYPORT had a higher percentage of tumor necrosis at the 90% cutoff, achieving 27% compared with 6% for CONV-RT (P = .003). At a median follow-up of 32 months, 12 patients (9%) experienced loco-regional recurrence, 24 patients (19%) faced distant failure, and 19 patients (15%) died of metastatic disease. Patients with <90% necrosis had higher rates of loco-regional (13% vs 0%, P = .207) and distant failure (25% vs 0%, P = .021). Three-year LRFS was 86% for <90% necrosis and 100% for >= 90% necrosis (P = .160). DDFS was 75% for <90% necrosis versus 100% for >= 90% (P = .036). OS rates were 79% and 93%, respectively (P = .290). Conclusions: Preoperative RT with UHYPO-RT was associated with a higher rate of tumor necrosis >= 90% than CONV-RT. Our data suggest that more extensive necrosis is associated with better clinical outcomes. (c) 2024 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:e189 / e197
页数:9
相关论文
共 50 条
  • [41] The Correlation Between Lymphocyte Nadir and Radiation Therapy for Soft Tissue Sarcoma: Defining Key Dosimetric Parameters and Outlining Clinical Significance
    Ku, Eric
    Harada, Garrett
    Chiao, Elaine
    Rao, Pranathi
    Hosseinian, Sina
    Seyedin, Steven
    Healy, Erin
    Maxim, Peter
    Chow, Warren
    Stitzlein, Russell
    Limoli, Charles
    Harris, Jeremy
    ADVANCES IN RADIATION ONCOLOGY, 2024, 9 (01)
  • [42] Clinical outcomes of limb salvage surgery with postoperative intensity-modulated radiation therapy for soft-tissue sarcoma and metastasis
    Kawanami, Katsuhisa
    Matsuo, Toshihiro
    Yuki, Shintaro
    Shimose, Shoji
    Takahashi, Ryosuke
    Deie, Masataka
    INDIAN JOURNAL OF CANCER, 2018, 55 (02) : 176 - 178
  • [43] Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma
    Bedi, Meena
    Singh, Reena
    Charlson, John A.
    Kelly, Tracy
    Johnstone, Candice
    Wooldridge, Adam
    Hackbarth, Donald A.
    Moore, Nicole
    Neilson, John C.
    King, David M.
    ADVANCES IN RADIATION ONCOLOGY, 2022, 7 (03)
  • [44] Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial
    Mowery, Yvonne M.
    Ballman, Karla, V
    Hong, Angela M.
    Schuetze, Scott M.
    Wagner, Andrew J.
    Monga, Varun
    Heise, Rachel S.
    Attia, Steven
    Choy, Edwin
    Burgess, Melissa A.
    Bae, Susie
    Pryor, David, I
    Tine, Brian A. Van
    Tinoco, Gabriel
    Chmielowski, Bartosz
    Freeman, Carolyn
    Gronchi, Alessandro
    Meyer, Christian F.
    Dickson, Mark A.
    Hartner, Lee
    Davis, Lara E.
    Powers, Benjamin C.
    Moding, Everett J.
    Weinhold, Kent J.
    van de Rijn, Matt
    Briqman, Brian E.
    Riedel, Richard F.
    Kirsch, David G.
    LANCET, 2024, 404 (10467): : 2053 - 2064
  • [45] Tumor Grade & Preoperative Therapy Impact the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts (PDOX): UCLA Sarcoma Program Prospective Clinical Trial
    Russell, T.
    Elliott, I. A.
    Eckardt, M.
    Murakami, T.
    Singh, A.
    Kiyuna, T.
    Igarashi, K.
    Kawaguchi, K.
    Li, Y.
    Crompton, J.
    Dry, S. M.
    Federman, N.
    Chmielowski, B.
    Shurrell, E.
    Hoffman, R.
    Eilber, F. C.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S30 - S31
  • [46] Tumor Necrosis Quantification on Imaging as a Predictor of Therapy Response for Soft-Tissue Sarcoma-Comparison between Estimates Obtained by MRI Volumetry and Pathology
    Singh, A.
    Harmon, D.
    Rosenthal, D.
    Lawrimore, T.
    Cai, W.
    Yoshida, H.
    Mcgowan, J.
    Harris, G.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (05)
  • [47] Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma
    O'Sullivan, Brian
    Griffin, Anthony M.
    Dickie, Colleen I.
    Sharpe, Michael B.
    Chung, Peter W. M.
    Catton, Charles N.
    Ferguson, Peter C.
    Wunder, Jay S.
    Deheshi, Benjamin M.
    White, Lawrence M.
    Kandel, Rita A.
    Jaffray, David A.
    Bell, Robert S.
    CANCER, 2013, 119 (10) : 1878 - 1884
  • [48] A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma
    Roeder, Falk
    Schulz-Ertner, Daniela
    Nikoghosyan, Anna V.
    Huber, Peter E.
    Edler, Lutz
    Habl, Gregor
    Krempien, Robert
    Oertel, Susanne
    Saleh-Ebrahimi, Ladan
    Hensley, Frank W.
    Buechler, Markus W.
    Debus, Juergen
    Koch, Moritz
    Weitz, Juergen
    Bischof, Marc
    BMC CANCER, 2012, 12
  • [49] A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma
    Falk Roeder
    Daniela Schulz-Ertner
    Anna V Nikoghosyan
    Peter E Huber
    Lutz Edler
    Gregor Habl
    Robert Krempien
    Susanne Oertel
    Ladan Saleh-Ebrahimi
    Frank W Hensley
    Markus W Buechler
    Juergen Debus
    Moritz Koch
    Juergen Weitz
    Marc Bischof
    BMC Cancer, 12
  • [50] The landscape of gene mutations and clinical significance of tumor mutation burden in patients with soft tissue sarcoma who underwent surgical resection and received conventional adjuvant therapy
    Xu, Li-Bin
    Zhao, Zhen-Guo
    Xu, Song-Feng
    Zhang, Xin-Xin
    Liu, Ting
    Jing, Chang-You
    Zhang, Shu-Guang
    Yu, Sheng-Ji
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2020, 35 (03): : 14 - 22